Suppressive therapy is a treatment approach where you take medication every day to prevent a condition from flaring up, rather than waiting for symptoms to appear and treating them after the fact. The term comes up most often with genital herpes (HSV), but it also applies to HIV management, recurrent urinary tract infections, and certain other chronic viral infections. The core idea is the same across all of them: consistent, daily medication keeps the problem quiet instead of chasing it after it surfaces.
How Suppressive Therapy Differs From Episodic Treatment
With episodic treatment, you start taking medication when you notice the first signs of a flare, such as tingling, sores, or burning. The goal is to shorten that individual episode and reduce its severity. You stop the medication once the outbreak resolves.
Suppressive therapy flips this model. You take a lower dose of the same type of medication every single day, whether or not you have symptoms. This keeps a steady level of the drug in your system, which prevents the virus from reactivating or keeps bacterial infections from recurring. For many people, this means going months or even years without a single episode. Even those who still get occasional breakthroughs typically find them shorter and milder than they would be without daily treatment.
Suppressive Therapy for Genital Herpes
Genital herpes is the condition most commonly managed with suppressive therapy. The herpes virus lives permanently in nerve cells and periodically reactivates, causing outbreaks of painful sores. Daily antiviral medication works by blocking the virus’s ability to copy itself, which dramatically reduces both visible outbreaks and the invisible “shedding” periods when the virus is active on the skin without causing symptoms.
The CDC notes that even people with mild or infrequent outbreaks can benefit from antiviral therapy, so there’s no strict cutoff for who qualifies. That said, suppressive therapy is most commonly discussed for people experiencing frequent recurrences. For those with 10 or more outbreaks per year, higher or more frequent dosing may be needed, since the lowest standard regimen can be less effective at that level of activity.
One of the most meaningful benefits is reducing the risk of passing herpes to a sexual partner. The virus can transmit even when no sores are present, during those asymptomatic shedding periods. Daily suppressive therapy significantly cuts down on shedding, which lowers the chance of transmission to a partner who doesn’t carry the virus.
Drug Resistance Is Rare in Healthy People
A common concern about taking antivirals indefinitely is whether the virus will stop responding to the medication. For people with healthy immune systems, drug-resistant herpes develops in less than 1% of cases, and when it does appear, it typically clears without serious consequences. The risk is higher for people with weakened immune systems, such as organ transplant recipients or those with advanced HIV, where resistance rates range from 3.5% to 14%. For the average person on long-term suppressive therapy, resistance is not a practical concern.
Suppressive Therapy in HIV Treatment
In the context of HIV, “viral suppression” refers to keeping the amount of virus in the blood below a specific threshold through daily antiretroviral therapy. A viral load below 200 copies per milliliter of blood is classified as suppressed. With newer, more sensitive tests, HIV is considered undetectable at 20 to 50 copies per milliliter.
This distinction matters enormously for transmission. Studies consistently show that a person with a viral load below 200 copies per milliliter cannot transmit HIV through sex. This is the basis of the widely cited U=U principle: undetectable equals untransmittable. Achieving and maintaining viral suppression requires taking antiretroviral medication every day without interruption, which is why adherence is so central to HIV care.
Long-term antiretroviral therapy does carry some risks that differ from herpes antivirals. Over years or decades of treatment, potential concerns include changes in cholesterol and blood sugar, reduced bone density, kidney stress, and neuropsychiatric effects. Modern treatment regimens have been designed to minimize these issues, and when a specific medication causes problems, switching to an alternative within the same overall regimen is usually straightforward. The benefits of sustained viral suppression, both for personal health and for preventing transmission, far outweigh these manageable risks for the vast majority of people.
Suppressive Therapy for Recurrent UTIs
Women who experience multiple urinary tract infections per year are sometimes prescribed a low daily dose of antibiotics to prevent new infections from taking hold. This is considered the gold standard for preventing recurrent UTIs, though it requires a commitment of at least six months of daily medication and strong adherence to work properly.
Some people start with a less intensive approach, taking a single dose of an antibiotic after specific triggers like sexual intercourse. This targeted strategy appears to work about as well as daily prophylaxis for many people and causes fewer gastrointestinal side effects. If it doesn’t keep infections away, the next step is the continuous daily regimen. The main trade-off with long-term antibiotic use is the increased risk of antibiotic resistance, which is why this approach is typically reserved for people who have already tried other preventive measures without success.
The Psychological Benefits
Beyond the physical effects, suppressive therapy often has a substantial impact on mental health. Living with a condition that can flare unpredictably creates a background hum of anxiety. For people with herpes, this can include worry about outbreaks during important events, stress about disclosing their status to partners, and fear of unknowingly transmitting the virus. Taking a daily pill that reliably prevents most of these scenarios gives people a sense of control that episodic treatment simply doesn’t provide.
For people living with HIV, achieving an undetectable viral load removes the possibility of sexual transmission entirely. The psychological weight that lifts when someone learns they cannot pass the virus to a partner is difficult to overstate. This shift from managing a transmissible infection to living with a controlled chronic condition changes how people relate to their diagnosis, their partners, and their own bodies.
What Daily Treatment Actually Looks Like
For herpes, suppressive therapy typically involves taking one small pill once or twice a day. Most people tolerate it well with minimal side effects. Periodic check-ins with a healthcare provider are standard, partly to assess whether the medication is still needed. Some people find that after a year or more on suppressive therapy, their outbreak frequency has decreased enough to try stopping the daily medication and switching to episodic treatment instead.
For HIV, the regimen is also usually a single pill taken once daily, though it contains a combination of active ingredients. The key difference is that HIV suppressive therapy is lifelong. Stopping antiretroviral medication allows the virus to rebound, often within days to weeks, so interruptions are strongly discouraged.
For recurrent UTIs, the daily antibiotic is taken for a defined period, usually six to twelve months, after which the need for continued treatment is reassessed. Many people find that the cycle of recurrent infections breaks during this window and doesn’t return immediately after stopping.
Is Suppressive Therapy Right for You?
The decision depends on how much the condition affects your daily life. For herpes, someone with one mild outbreak a year may prefer episodic treatment, while someone with six outbreaks, a new partner, or significant anxiety about transmission may find that daily medication transforms their quality of life. For HIV, suppressive therapy isn’t optional in the way it is for herpes. It’s the foundation of treatment and the single most effective tool for staying healthy and preventing transmission.
Cost and convenience also play a role. Generic antiviral medications for herpes are widely available and inexpensive. Antiretroviral therapy for HIV has become more accessible through insurance coverage and assistance programs, though it remains more complex. For recurrent UTIs, the antibiotics used are generally low-cost, but the risk of resistance means the decision involves weighing short-term relief against longer-term consequences for your body’s relationship with antibiotics.